Sign inJoin waitlistJoin the waitlist

Sara Char

Physician · Mass General Brigham

Credentials: · · ·

History

Dana-Farber Cancer Institute
2026–Present

Hematology and Medical Oncology
Dana-Farber Cancer Institute
2022–2025
Internal Medicine
Massachusetts General Hospital
2019–2022
Tufts University School of Medicine
2015–2019

Research

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status
Journal of Thoracic Oncology · 2022 · 357 citations
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
Annals of Oncology · 2019 · 271 citations
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50
Annals of Oncology · 2020 · 101 citations

Biagio Ricciuti
3 papers · 1 as a resident
John Heymach
3 papers
JG
Justin Gainor
3 papers
KA
Kathryn Arbour
3 papers
Kimmie Ng
3 papers
MA
Mark Awad
3 papers
MH
Matthew Hellmann
3 papers
SD
Subba Digumarthy
3 papers
Brett Carter
2 papers
Ferdinandos Skoulidis
2 papers
Jennifer Sauter
2 papers
Jianjun Zhang
2 papers